UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chromatin modifiers and the promise of epigenetic therapy in acute leukemia

Leukemia, 2014-07, Vol.28 (7), p.1396-1406

2014

Volltextzugriff (PDF)

Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML

Leukemia, 2018-02, Vol.32 (2), p.499-509

2018

Volltextzugriff (PDF)

Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1

Oncogene, 2008-07, Vol.27 (31), p.4293-4304

2008

Volltextzugriff (PDF)

Loss of p300 accelerates MDS-associated leukemogenesis

Leukemia, 2017-06, Vol.31 (6), p.1382-1390

2017

Volltextzugriff (PDF)

Report of an international working group to standardize response criteria for myelodysplastic syndromes

Blood, 2000-12, Vol.96 (12), p.3671-3674

2000

Volltextzugriff (PDF)

Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2003-10, Vol.32 (7), p.673-679

2003

Volltextzugriff (PDF)

High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease

Bone marrow transplantation (Basingstoke), 2008-09, Vol.42 (6), p.405-412

2008

Volltextzugriff (PDF)

Tumor promoting properties of the ETS protein MEF in ovarian cancer

Oncogene, 2007-06, Vol.26 (27), p.4032-4037

2007

Volltextzugriff (PDF)

Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients

Bone marrow transplantation (Basingstoke), 2010-10, Vol.45 (10), p.1522-1527

2010

Volltextzugriff (PDF)

Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3776-3785

1999

Volltextzugriff (PDF)

Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

Haematologica (Roma), 2013-06, Vol.98 (6), p.908-912

2013

Volltextzugriff (PDF)

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma

Annals of oncology, 2007-11, Vol.18 (11), p.1842-1850

2007

Volltextzugriff (PDF)

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Leukemia, 2014-05, Vol.28 (5), p.1033-1040

2014

Volltextzugriff (PDF)

Autologous stem cell transplantation in multiple myeloma patients <60 vs ≥60 years of age

Bone marrow transplantation (Basingstoke), 2003-12, Vol.32 (12), p.1135-1143

2003

Volltextzugriff (PDF)

Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis

Leukemia, 2008-09, Vol.22 (9), p.1792-1794

2008

Volltextzugriff (PDF)

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma

Clinical cancer research, 1998-02, Vol.4 (2), p.311-316

1998

Volltextzugriff (PDF)

Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia

Leukemia, 2007-03, Vol.21 (3), p.563-566

2007

Volltextzugriff (PDF)

Results of a phase I II trial adding carmustine (300 mg m ) to melphalan (200 mg m ) in multiple myeloma patients undergoing autologous stem cell transplantation

Leukemia, 2006-02, Vol.20 (2), p.345-349

2006

Volltextzugriff (PDF)

AML1A and AML1B can transactivate the human IL-3 promoter

The Journal of immunology (1950), 1997-03, Vol.158 (5), p.2251-2258

1997

Volltextzugriff (PDF)

Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial

Bone marrow transplantation (Basingstoke), 2005-03, Vol.35 (5), p.441-447

2005

Volltextzugriff (PDF)

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Leukemia, 2015-12, Vol.29 (12), p.2452-2452

2015

Volltextzugriff (PDF)

Transcription Factors, Translocations, and Leukemia

Blood, 1992-12, Vol.80 (12), p.2953-2963

1992

Volltextzugriff (PDF)

Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter

Molecular and Cellular Biology, 1995-11, Vol.15 (11), p.6055-6063

1995

Volltextzugriff (PDF)

The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma

Bone marrow transplantation (Basingstoke), 1999-03, Vol.23 (6), p.561-567

1999

Volltextzugriff (PDF)

1 – 25 von 559

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(520)
Mit Volltextzugriff
(479)

Publikationsform

Sprache

Englisch
(552)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(331)
Life Sciences & Biomedicine
(291)
Humans
(277)
Hematology
(123)
Biological And Medical Sciences
(115)
Animals
(104)
Female
(99)
Male
(98)
Medical Sciences
(98)
Oncology
(87)
Adult
(83)
Middle Aged
(81)
Mice
(76)
Cell Biology
(67)
Aged
(63)
Hematologic And Hematopoietic Diseases
(54)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(45)
Treatment Outcome
(45)
Mutation
(39)
Leukemia
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(139)
Leukemia
(16)
Oncogene
(14)
British Journal Of Haematology
(13)
Cancer Research
(13)
Proceedings Of The National Academy Of Sciences - Pnas
(11)
World Neurosurgery
(11)
Bone Marrow Transplantation
(10)
Leukemia Research
(10)
Molecular And Cellular Biology
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Chromatin modifiers and the promise of epigenetic therapy in acute leukemia

Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML

Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1

Loss of p300 accelerates MDS-associated leukemogenesis

Report of an international working group to standardize response criteria for myelodysplastic syndromes

Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma

High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease

Tumor promoting properties of the ETS protein MEF in ovarian cancer

Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients

Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Autologous stem cell transplantation in multiple myeloma patients <60 vs ≥60 years of age

Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma

Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia

Results of a phase I II trial adding carmustine (300 mg m ) to melphalan (200 mg m ) in multiple myeloma patients undergoing autologous stem cell transplantation

AML1A and AML1B can transactivate the human IL-3 promoter

Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

Transcription Factors, Translocations, and Leukemia

Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma

Suchergebnisse filtern